Literature DB >> 12795713

Antibodies to myelin-associated glycoprotein accelerate preferential motor reinnervation.

Simon Mears1, Melitta Schachner, Thomas M Brushart.   

Abstract

Predegeneration of nerve enhances its ability to support axon regeneration. Trophic factors are upregulated by reactive Schwann cells while potentially inhibitory molecules are removed. These experiments isolate the effects of one such inhibitory molecule, the myelin-associated glycoprotein (MAG), to determine its role in modifying regeneration after nerve repair. Suture of the mouse femoral nerve was followed by daily intraperitoneal injection of antibodies to MAG, antibodies to HNK-1, a specific muscle pathway marker, or no further treatment. Regeneration was assayed by double-labeling the femoral cutaneous and muscle branches with horseradish peroxidase and fluoro-gold after 4 weeks or 6 weeks of regeneration. Four weeks after nerve repair, selective reinnervation of the muscle branch by motoneurons, or preferential motor reinnervation (PMR), was not seen in either controls or L2-antibody-treated animals. In contrast, treatment with MAG antibodies resulted in dramatic PMR. By 6 weeks, the controls had achieved borderline specificity, substantial PMR developed in the L2 antibody group and the MAG group changed little. Blocking access to MAG in the distal nerve stump thus accelerated and enhanced PMR. Sensory regeneration was depressed by both antibody treatments at 4 weeks but recovered by 6 weeks. Antibody administration has a generalized effect on sensory regeneration that is unrelated to the behavior of motoneurons in the same nerve.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12795713     DOI: 10.1046/j.1529-8027.2003.03012.x

Source DB:  PubMed          Journal:  J Peripher Nerv Syst        ISSN: 1085-9489            Impact factor:   3.494


  11 in total

1.  Sialidase enhances spinal axon outgrowth in vivo.

Authors:  Lynda J S Yang; Ileana Lorenzini; Katarina Vajn; Andrea Mountney; Lawrence P Schramm; Ronald L Schnaar
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-17       Impact factor: 11.205

2.  Reduced BACE1 activity enhances clearance of myelin debris and regeneration of axons in the injured peripheral nervous system.

Authors:  Mohamed H Farah; Bao Han Pan; Paul N Hoffman; Dana Ferraris; Takashi Tsukamoto; Thien Nguyen; Philip C Wong; Donald L Price; Barbara S Slusher; John W Griffin
Journal:  J Neurosci       Date:  2011-04-13       Impact factor: 6.167

Review 3.  The neuroprotective role of inflammation in nervous system injuries.

Authors:  Jorge Correale; Andrés Villa
Journal:  J Neurol       Date:  2004-11       Impact factor: 4.849

Review 4.  Roles of channels and receptors in the growth cone during PNS axonal regeneration.

Authors:  Sangwoo Shim; Guo-li Ming
Journal:  Exp Neurol       Date:  2009-10-13       Impact factor: 5.330

5.  Novel roles for osteopontin and clusterin in peripheral motor and sensory axon regeneration.

Authors:  Megan C Wright; Ruifa Mi; Emmalynn Connor; Nicole Reed; Alka Vyas; Manula Alspalter; Giovanni Coppola; Daniel H Geschwind; Thomas M Brushart; Ahmet Höke
Journal:  J Neurosci       Date:  2014-01-29       Impact factor: 6.167

6.  Adult motor axons preferentially reinnervate predegenerated muscle nerve.

Authors:  M Abdullah; A O'Daly; A Vyas; C Rohde; T M Brushart
Journal:  Exp Neurol       Date:  2013-08-08       Impact factor: 5.330

7.  Reinnervation of the tibialis anterior following sciatic nerve crush injury: a confocal microscopic study in transgenic mice.

Authors:  Christina K Magill; Alice Tong; David Kawamura; Ayato Hayashi; Daniel A Hunter; Alexander Parsadanian; Susan E Mackinnon; Terence M Myckatyn
Journal:  Exp Neurol       Date:  2007-06-14       Impact factor: 5.330

8.  GSK249320, A Monoclonal Antibody Against the Axon Outgrowth Inhibition Molecule Myelin-Associated Glycoprotein, Improves Outcome of Rodents with Experimental Stroke.

Authors:  Diana Cash; Alanna C Easton; Michel Mesquita; John Beech; Steve Williams; Andrew Lloyd; Elaine Irving; Steven C Cramer
Journal:  J Neurol Exp Neurosci       Date:  2016-11-21

9.  Proof-of-Concept Randomized Trial of the Monoclonal Antibody GSK249320 Versus Placebo in Stroke Patients.

Authors:  Steven C Cramer; Lori A Enney; Colleen K Russell; Monica Simeoni; Thomas R Thompson
Journal:  Stroke       Date:  2017-02-22       Impact factor: 7.914

10.  Functions of Small Organic Compounds that Mimic the HNK-1 Glycan.

Authors:  Minjuan Wang; Thomas Theis; Maciej Kabat; Gabriele Loers; Lynn A Agre; Melitta Schachner
Journal:  Int J Mol Sci       Date:  2020-09-24       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.